ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 83K)  | Related Articles | Citation Tracking

Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care
Maja Jekovec-VrhovsěkMD Mph, Child Neurologist* 1 , Andreja Kocijancic MD PhD, Professor 2 , Janez Preželj MD PhD, Professor 3
  1 Head of Medical Services, Center Dolfke Bostjancic Draga, Diabetes and Metabolic Diseases, Ljubljana, Slovenia   2 Head of Clinics for Endocrinology, Diabetes and Metabolic Diseases, Ljubljana, Slovenia   3 Head of Department of Endocrinology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  * Correspondence to first author at Center Dolfke Boštjančič Draga, Dobravica 28, 1292 Igpri Ljubljani, Slovenia.
Copyright 2000 Mac Keith Press

ABSTRACT

Atraumatic fractures are often seen in children and adolescents with cerebral palsy (CP) and epilepsy in full-time care. Increased bone fragility was postulated to be due to osteopenia resulting from a combination of factors including immobilization and antiepileptic treatment. The aim of this study was to determine the effect of vitamin D and calcium substitution on bone mineral density (BMD) in a group of children with CP in full-time care. Twenty children with the most severe form of CP (spastic quadriplegia) who had been treated with antiepileptic drugs for a relatively long period of time were included in the study. Physical examination and laboratory analyses excluded other possible causes of osteopenia. BMD was measured by dual X-ray absorptiometry. Thirteen patients were treated for 9 months with 1,25-dihydroxy-cholecalciferol vitamin D (0.25 mcg daily) and with calcium (500 mg daily). Seven control children were used for observation only. BMD greatly increased in the treated group, while children with CP in full-time care who did not receive vitamin D and calcium substitution continued to lose their bone mass. It can be concluded that the addition of vitamin D and calcium increases BMD in children with the most severe form of CP, who are receiving antiepileptic drugs.


Accepted for publication 2nd December 1999.

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1469-8749.2000.tb00119.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Latest News & Information
Developmental Medicine & Child Neurology

Top of the basilar artery embolic stroke and neonatal myoclonus by Paul Govaert, Jeroen Dudink, Gerhard Visser, et al.

Videos accompanying this article can be viewed online as supporting information

EFNS 2009 - Register Now
Latest News & Information

Sign up for the Neurology NewsWire.

Neuro Newsletter

Get 6 free issues of breaking news and research delivered to your inbox each year!

Sign Up Now
Wiley Medical Twitter